- Signaling Pathways
- Vitamin D Related/Nuclear Receptor
- Estrogen Receptor/ERR
Estrogen Receptor/ERR
Estrogen Receptor/ERR Isoform Specific Products
All Product Categories
-
Estrogen Receptor/ERR Inhibitors
(134)
View all products
-
Estrogen Receptor/ERR Agonists
(162)
View all products
-
Estrogen Receptor/ERR Antagonists
(107)
View all products
-
Estrogen Receptor/ERR Activators
(51)
View all products
-
Estrogen Receptor/ERR Modulators
(119)
View all products
-
Estrogen Receptor/ERR Chemicals
(2)
View all products
-
Estrogen Receptor/ERR Degraders
(73)
View all products
-
Estrogen Receptor/ERR Controls
(6)
View all products
-
Estrogen Receptor/ERR Ligands
(29)
View all products
-
Estrogen Receptor Proteins
(2)
View all products
-
ER-alpha Proteins
(1)
View all products
-
ER-beta Proteins
(1)
View all products
-
Estrogen Receptor/ERR Related Products (823)
Related Products (823)
-
Recombinant Proteins (2)
-
Antibodies (11)
-
Estrogen Receptor/ERR Isoform Comparison
-
α-Zearalenol (Standard)
0 ImagesCat. No.: HY-N6710RCAS No.: 36455-72-8α-Zearalenol (Standard) is the analytical standard of α-Zearalenol. This product is intended for research and analytical applications. α-Zearalenol is a Mycotoxin with high affinity for the estrogen receptors (ER), α-Zearalenol is the derivative of zearalenone (ZEN), causes reproductive disorders in animals, due to its xenoestrogenic effects. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
HIT-2
0 ImagesCat. No.: HY-181171HIT-2 is an estrogen receptor alpha (ERα) inhibitor that can bind to the ERα ligand binding domain. HIT-2 forms stable interactions including hydrogen bonds, π-π stacking, and hydrophobic contacts to disrupt ERα-driven signaling. HIT-2 exhibits antineoplastic activity against breast cancer. HIT-2 can be used for the research of breast cancer. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
ERα degrader 6
0 ImagesCat. No.: HY-149081CAS No.: 2775441-10-4ERα degrader 6 is a selective dual-targeting estrogen receptor α (ERα) degrader. ERα degrader 6 induces ERα degradation, aromatase inhibition, and exerts antiproliferative effects in endocrine-resistant breast cancer cells. ERα degrader 6 can be used for research related to endocrine-resistant breast cancer. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
Yp537
0 ImagesCat. No.: HY-P3833CAS No.: 166664-90-0Synonyms: Anti-estrogenYp537 is an estrogen receptor (ER) inhibitor that blocks dimerization of the human estrogen receptor. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
OBHS
0 ImagesCat. No.: HY-146424CAS No.: 870614-18-9OBHS is an estrogen receptor α (ERα) inhibitor. OBHS can also be used as a blowing agent. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
- PROTAC ER Degrader-10
-
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
- FRAGHIT-4
-
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
(1S,3R)-GNE-502
0 ImagesCat. No.: HY-132294ACAS No.: 1953134-15-0(1S,3R)-GNE-502 (compound 179) is a potent ERα degrader with an EC50 value of 13 nM against ERα in MCF7 HCS. (1S,3R)-GNE-502 can be used to research cancer related with estrogen receptor. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
KAT6-IN-4
0 ImagesCat. No.: HY-177445CAS No.: 2901797-38-2KAT6-IN-4 (Compound Example 2) is a selective lysine acetyltransferase 6 (KAT6) inhibitor. KAT6-IN-4 suppresses transcription of oncogenes like ERα. KAT6-IN-4 demonstrates potent antitumor efficacy in ER+/HER2- breast cancer xenografts. KAT6-IN-4 is promising for research of KAT6-driven malignancies (e.g., breast cancer, NSCLC). -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
HSD17B13-IN-94
0 ImagesCat. No.: HY-162220CAS No.: 2848620-90-4HSD17B13-IN-94 (Compound 12) is an effective inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of ≤ 0.1 μM for Estradiol (HY-B0141). HSD17B13-IN-94 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD, NASH, or drug-induced liver injury (DILI). -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
GPER/Bcl-2-IN-1
0 ImagesCat. No.: HY-174338GPER/Bcl-2-IN-1 is a GPER/Bcl-2 inhibitor. GPER/Bcl-2-IN-1 can inhibit the proliferation and neurospheres formation of glioblastoma cells. GPER/Bcl-2-IN-1 can be used for the study of glioblastoma multiforme (GBM). -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
CS-1-103
0 ImagesCat. No.: HY-179238CS-1-103 is a potent estrogen receptor (ER) TRACER (transcriptional regulation via active control of epigenetic reprogramming). CS-1-103 inhibits ER transcriptional activity with an EC50 of 0.36 μM by recruiting methyl-CpG binding domain protein 2 (MBD2), HDACs and the nucleosome remodeling and deacetylase (NuRD) complex. CS-1-103 can be used for breast and prostate cancer research. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
BY13
0 ImagesCat. No.: HY-176225CAS No.: 3117131-00-4BY13 is a SRC-3 PROTAC degrader with a DC50 of 0.031 μM. BY13 selectively blocks the ER signaling pathway over that of androgen receptor (AR)) through down-regulating ERα level. BY13 potently overcomes endocrine resistance in breast cancer by inducing cell cycle arrest in G1 phase and apoptosis, with superior effect over Fulvestrant (HY-13636). BY13 significantly inhibits the growth of drug-resistant breast tumors without obvious toxicity in LCC2 xenograft mice model. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
PROTAC ER Degrader-2
0 ImagesCat. No.: HY-128528PROTAC ER Degrader-2 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab). -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
Anticancer agent 347
0 ImagesAnticancer agent 347 is a heterobifunctional anticancer inhibitor with inhibitory activity against ERα-overexpressing cells and breast cancer cells. Anticancer agent 347 can be used for the research of breast cancer. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
PSDalpha
0 ImagesCat. No.: HY-144314CAS No.: 2906869-08-5PSDalpha is a photoactivatable PS-Degron targeting estrogen receptor α (ERα/ESR1), with a Ki of 72.8 nM for ERα. PSDalpha consists of an ERα-targeting estradiol moiety conjugated via an alkyne bond to triphenylamine-benzothiadiazole (TB), an aggregation-induced emission (AIE) photosensitizer. Upon visible light irradiation, PSDalpha generates singlet oxygen (1O2) and induces controllable ERα degradation. PSDalpha also induces G1 phase arrest and apoptosis. PSDalpha can be used in studies related to ERα-positive breast cancer and light-controlled targeted protein degradation. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
Anticancer agent 352
0 ImagesCat. No.: HY-184960CAS No.: 3099599-58-0Anticancer agent 352 is a heterobifunctional anticancer compound. Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A). Anticancer agent 352 can be used in breast cancer-related research. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
3'-Hydroxymirificin
0 ImagesCat. No.: HY-N11438CAS No.: 168035-02-73'-Hydroxymirificin (compound 3) is a naural compound that can be isolated from Pueraria lobata roots. 3'-Hydroxymirificin (compound 3) possesses estrogenic activity and anti-proliferation of MCF-7 human breast carcinoma cells. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
Panomifene
0 ImagesCat. No.: HY-122411CAS No.: 77599-17-8Synonyms: EGIS 5650; GYKI-13504 -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
- LSD1/ER-IN-1
-
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
No matching results
No matching results
No matching results
No matching results
-
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
Your Search Returned No Results.
Sorry. There is currently no product that acts on isoform Bcl-2, Bcl-W and Bim together.Please
try each isoform separately.